Nexviadyme Uniunea Europeană - română - EMA (European Medicines Agency)

nexviadyme

sanofi b.v. - avalglucosidase alfa - glicogenul de boală de tip ii - alte medicamente pentru tractul digestiv și metabolism, - nexviadyme (avalglucosidase alfa) is indicated for long-term enzyme replacement therapy for the treatment of patients with pompe disease (acid α-glucosidase deficiency).

Xenpozyme Uniunea Europeană - română - EMA (European Medicines Agency)

xenpozyme

sanofi b.v. - olipudase alfa - acid sphingomyelinase deficiency (asmd) type a/b or type b - alte medicamente pentru tractul digestiv și metabolism, - xenpozyme is indicated as an enzyme replacement therapy for the treatment of non-central nervous system (cns) manifestations of acid sphingomyelinase deficiency (asmd) in paediatric and adult patients with type a/b or type b.

Renagel Uniunea Europeană - română - EMA (European Medicines Agency)

renagel

sanofi b.v. - sevelamer - renal dialysis; hyperphosphatemia - toate celelalte produse terapeutice - renagel is indicated for the control of hyperphosphataemia in adult patients receiving  haemodialysis or peritoneal dialysis. renagel should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 - dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.

Exforge H comprimate filmate 160 mg + 10 mg + 12,5 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

exforge h comprimate filmate 160 mg + 10 mg + 12,5 mg

novartis pharma ag - enalaprilum + amlodipinum + hydrochlorothiazidum - comprimate filmate - 160 mg + 10 mg + 12,5 mg

Exforge H comprimate filmate 160 mg + 5 mg + 12,5 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

exforge h comprimate filmate 160 mg + 5 mg + 12,5 mg

novartis pharma ag - enalaprilum + amlodipinum + hydrochlorothiazidum - comprimate filmate - 160 mg + 5 mg + 12,5 mg